Mission Pharmacal Company

A notable focus of the US Food and Drug Administration during the tenure of Scott Gottlieb centered on the regulatory "gaming" tactics used by branded industry to prevent generic competition from reac

A notable focus of the US Food and Drug Administration during the tenure of Scott Gottlieb centered on the regulatory "gaming" tactics used by branded industry to prevent generic competition from reac

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Takeda Licenses STING Agonis

The Association for Accessible Medicines (AAM) has contended that the US FDA's public list of drug companies suspected of using risk evaluation and mitigation strategies (REMS) to stonewall generic de